It's not about being right, it's about making money. There's a difference and I think that gets forgotten too often. We want to position ourselves where we have the highest probabilities for success as well as where the risk vs reward is skewed in our favor. The goal is not to be right every time. The goal is to be profitable. That's why we're always thinking worst case scenario: always a risk level and always a target.

Today I want to focus in on what we're seeing in the S&P500 because I think that from a risk management standpoint, this 2780-2800 level is a big one today from a structural perspective. Until now, we've used 7000 in the Nasdaq100 and 2650 in the S&P500 as our lines in the sand. We've only wanted to be long if we were above those levels and that has worked out very well. Moving forward, I've identified some higher levels that we need to monitor.

As part of our ongoing partnership with Investor's Business Daily we have added all of the IBD50 components to our equity research coverage. We are updating our Chartbook on a weekly basis and members of Allstarcharts have access to that workbook here.

Today, I wanted to discuss what we're seeing from this group to identify the overall trend for U.S. stocks and also to find trading ideas to profit from that directional move. 

This index is made up of stocks showing both relative strength and positive momentum, in addition to other factors that play a role in adding or removing components from the list of 50. What attracts me to this group, however, is the relative strength and positive momentum, just to be clear.

This is the Innovator IBD50 ETF $FFTY which to me, is still in an uptrend. We want to continue to err on the bullish side of this ETF and the group as a whole:

If you've been reading our blog for a while, you're probably familiar with our process and how we identify reward/risk scenarios that are ridiculously skewed in our favor. With that said, the way we accomplish that doesn't always look exactly the same. Sometimes we're buying breakouts and trading with the trend, other times we're trading against the trend for mean reversion, and other times it's some combination of strategies.

Life isn't just about Tesla gossip and Apple at a trillion. There is plenty of "less sexy" market behavior to be paying attention to right now that should have serious implications for the overall market. While boring to some, we have a huge amount of respect for Berkshire Hathaway stock. The breakout we got this week is likely to be the beginning of a 25% move higher which should take this one close to a $700B market cap and we want to be buying!

This entire year we've been talking about under-performance in the mid-cap and small-cap segments of the market. To take advantage of that we've wanted to be shorting, or at least avoiding longs in, the weakest names in sectors like Public Sector Banks, Infrastructure, Metals, Media, Realty, etc. Last month many of our downside price targets were hit from a tactical perspective and we took a more neutral approach, waiting for better entries on the short side. Now that we've seen a multi-week bounce off the lows in the mid and small-cap indexes, we're going to revisit the space for the best reward/risk setups on the short side.

From the desk of Tom Bruni @BruniCharting

There's been a lot of talk about equity market breadth both in the US and globally, but one thing I've not seen mentioned throughout the debate is Dow Theory. While there are five tenets of Dow Theory, today I want to focus on the aspect regarding confirmation among the three averages: The Dow Jones Industrial Average, The Dow Jones Transportation Average, and The Dow Jones Utility Average, by assessing their primary trends.

Sponsored by Investor’s Business Daily - Todd Sohn does amazing work on a daily basis. We're constantly communicating and sharing ideas with one another. I can tell you for a fact, there are few people in this world who look through as many charts as Todd. Our process is similar so I have really been looking forward to this conversation. We covered a lot of topics in this episode including U.S. Stocks and the sector rotation we've been seeing underneath the surface. Sentiment is a big part of their work over at Strategas and I find it really interesting how he incorporates analyst ratings to find ideas in the market. This is a good one!

From the desk of Tom Bruni @BruniCharting

Sector rotation in this market continues and the Agribusiness and Chemical Industries within the Materials Sector look to be heating up. While their performance on a relative basis is lackluster, on an absolute basis there are several setups offering reward/risk scenarios skewed in our favor.

First let's take a structural look at the Agribusiness ETF $MOO, which contains exposure to Chemical stocks as there is no ETF dedicated to that industry. Prices got back to their '08 highs earlier in the year and have been consolidating since. A breakout above 66 would signal the beginning of a new long-term uptrend that targets 94.25.

Click on chart to enlarge view.

From the desk of Tom Bruni @BruniCharting

Earlier this year I discussed what I look for when picking a bottom in a stock using Twitter as an example. Today I want to look at The Container Store because it's exhibiting similar characteristics that suggest the stock has begun a new long-term uptrend.

From the desk of Tom Bruni @BruniCharting

Every so often we hear the narrative that under-performance from China's stock market is a canary in the coal mine for US Equities, and the recent tariff tantrums have brought this discussion front and center. Today I want to look at this relationship to see if it has any merit or if it's just a smart sounding soundbite that you can use around the office water cooler.

From the desk of Tom Bruni @BruniCharting

We've been extremely vocal about the Medical Devices space on the blog, and rightfully so, with the sector continuing its long-term trend of out-performance throughout 2018. The index has 57 components, but because the top 10 stocks make up roughly 60% of the index, opportunities in the smaller components tend to be overlooked by many market participants. In this post I want to look at all of its components and highlight names where our risk is well-defined and the reward/risk is still skewed in our favor.

Let's start off with the sector ETF $IHI on an absolute basis for context. Prices are just off all-time highs after successfully retesting their breakout area near 203.50. As long as prices are above that level, short and intermediate-term momentum remains intact and our next upside objective is up near 248-249.50.

Most Nifty Indexes' largest components have a very large weighting on their performance, and Nifty Pharma is no exception. Sun Pharmaceuticals represents roughly a quarter of the index, so today we're going to look at it's role as a potential leading indicator for the rest of the sector.

Below is a daily line chart of the Nifty Pharma Index overlayed with Sun Pharmaceuticals. What we see from this relationship is that Sun Pharma generally leads the index, so when it's showing relative strength a move higher is likely, and when it's showing relative weakness then a move lower is likely. The two rarely separate from each other for long.